MY8700919A - Piperazine derivatives of theophylline - Google Patents

Piperazine derivatives of theophylline

Info

Publication number
MY8700919A
MY8700919A MY919/87A MY8700919A MY8700919A MY 8700919 A MY8700919 A MY 8700919A MY 919/87 A MY919/87 A MY 919/87A MY 8700919 A MY8700919 A MY 8700919A MY 8700919 A MY8700919 A MY 8700919A
Authority
MY
Malaysia
Prior art keywords
sub
chob
integer
zero
theophylline
Prior art date
Application number
MY919/87A
Other languages
English (en)
Inventor
Favier Colette
Pinhas Henri
Beranger Serge
Pascal Jean-Claude
Original Assignee
Laroche Navarron Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10511013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY8700919(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laroche Navarron Sa filed Critical Laroche Navarron Sa
Publication of MY8700919A publication Critical patent/MY8700919A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Fats And Perfumes (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
MY919/87A 1980-01-31 1987-12-30 Piperazine derivatives of theophylline MY8700919A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8003212 1980-01-31

Publications (1)

Publication Number Publication Date
MY8700919A true MY8700919A (en) 1987-12-31

Family

ID=10511013

Family Applications (1)

Application Number Title Priority Date Filing Date
MY919/87A MY8700919A (en) 1980-01-31 1987-12-30 Piperazine derivatives of theophylline

Country Status (18)

Country Link
US (1) US4374835A (da)
EP (1) EP0033674B1 (da)
JP (1) JPS56120683A (da)
KR (1) KR850000033B1 (da)
AT (1) ATE8994T1 (da)
AU (1) AU535339B2 (da)
CA (1) CA1154767A (da)
DE (1) DE3165464D1 (da)
DK (1) DK149814C (da)
ES (1) ES499511A0 (da)
GB (1) GB2069487B (da)
HK (1) HK88088A (da)
HU (1) HU187294B (da)
IE (1) IE50710B1 (da)
MY (1) MY8700919A (da)
NZ (1) NZ196157A (da)
YU (1) YU43487B (da)
ZA (1) ZA81160B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374837A (en) * 1981-07-31 1983-02-22 Laroche Navarron, S.A. Piperazine derivatives of theobromine
US4400381A (en) * 1981-07-31 1983-08-23 Laroche-Navarron, S.A. Piperazine derivatives of theophylline
US4713382A (en) * 1985-05-30 1987-12-15 Syntex (U.S.A.) Inc. N-phenyl-4-phenyl-1-piperazinecarboxamidines and related compounds as antiarrhythmic agents
US4810706A (en) * 1985-12-20 1989-03-07 Recherche Syntex Piperazine derivatives of theophylline and theobromine
WO1997035480A1 (en) * 1996-03-15 1997-10-02 Eli Lilly And Company Method of treating common cold or allergic rhinitis
US5869497A (en) * 1996-03-15 1999-02-09 Eli Lilly And Company Method of treating or ameliorating the symptoms of common cold or allergic rhinitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2534247A (en) * 1950-12-19 S-haloxantkine salts of i-diaryl
US3362506A (en) * 1964-01-10 1968-01-09 Bendix Corp Brake
GB1133989A (en) * 1964-12-08 1968-11-20 Chugai Pharmaceutical Co Ltd Theophylline derivatives, their salts and process for preparing the same
FR4625M (da) * 1965-05-03 1966-11-28
DE1620576A1 (de) * 1966-11-25 1970-02-26 Troponwerke Dinklage & Co Verfahren zur Herstellung von Theophyllin- und Theobrominverbindungen
ES377662A1 (es) * 1969-03-28 1973-01-01 Walter Bestian Procedimiento para la preparacion de nuevos compuestos de derivados de dialcohil-xantina.

Also Published As

Publication number Publication date
DK149814B (da) 1986-10-06
HU187294B (en) 1985-12-28
AU535339B2 (en) 1984-03-15
ATE8994T1 (de) 1984-09-15
EP0033674A3 (en) 1981-10-21
KR830005225A (ko) 1983-08-03
AU6635481A (en) 1981-08-06
GB2069487B (en) 1983-08-17
ZA81160B (en) 1982-02-24
YU43487B (en) 1989-08-31
GB2069487A (en) 1981-08-26
DK42481A (da) 1981-08-01
IE810141L (en) 1981-07-31
YU22681A (en) 1983-10-31
JPS56120683A (en) 1981-09-22
NZ196157A (en) 1983-02-15
ES8202344A1 (es) 1982-02-01
DK149814C (da) 1987-03-16
ES499511A0 (es) 1982-02-01
KR850000033B1 (ko) 1985-02-13
EP0033674B1 (en) 1984-08-15
DE3165464D1 (en) 1984-09-20
IE50710B1 (en) 1986-06-25
HK88088A (en) 1988-11-04
CA1154767A (en) 1983-10-04
US4374835A (en) 1983-02-22
EP0033674A2 (en) 1981-08-12
JPH0351712B2 (da) 1991-08-07

Similar Documents

Publication Publication Date Title
AU560141B2 (en) Piperazine derivatives of theophylline
ES8400430A1 (es) "un procedimiento para la preparacion de derivados piperacinicos de la teobromina".
DE3462890D1 (en) Pyridazinones, their preparation and use, medicines containing these pyridazinones
DE3165464D1 (en) Piperazine derivatives of theophylline
ES8304548A1 (es) "procedimiento de preparacion de derivados de fenetanolamina".
JPS5331669A (en) Novel n-acylpiperidinecaroxyanilide derivatives and their preparation
EP0204172A3 (en) Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use
JPS5430165A (en) 2-allylamino-5-phenyloxazoles and their pharmaceutically acceptable aicd salts
ES8202811A1 (es) Un procedimiento para la preparacion de derivados de benzo (1,4) dioxina
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
JPS5334779A (en) Novel piperazine derivatives and thier preparation
EP0110169A3 (en) 4-(benzisothiazol-3-yl)phenoxyacetic-acid l',l'-dioxides, a process for preparing the same, intermediates thereof and their use as medicaments
ES8102122A1 (es) Un procedimiento para obtener derivados de quinazolina
JPS5430161A (en) 2-aminomethylbenzoxazoles and their pharmaceutically acceptable acid salts
JPS5432492A (en) Novel cyclopropylmethylamine derivatives and their preparation
JPS5432482A (en) 3,4-dihydrocarbostyril derivatives and bactericides containing the same as active agnet for agricultural and horticultural uses
JPS5430166A (en) 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts